Moderna, IAVI to commence Phase I trial of mRNA HIV vaccine trial in Africa
The Phase I trial will analyse for safety and immunogenicity of the mRNA HIV vaccine antigen in African populations.

The Phase I trial will analyse for safety and immunogenicity of the mRNA HIV vaccine antigen in African populations.
The trial will analyse BIO 300’s ability to alleviate long-term pulmonary damage in Covid-19 survivors.
The trial will assess the safety and tolerability of oncolytic virus CF33-hNIS as monotherapy or along with pembrolizumab.
The trial is assessing the safety and efficacy of AVR-RD-04 in adults with the infantile form of cystinosis.
The trial will analyse the impact of setanaxib plus pembrolizumab in patients with CAF-density tumours.
Clinical Trials Arena spoke to experts who point to how additional study design parameters can measure and alleviate fertility risk.
ByThe US Food and Drug Administration approved dose escalation in the Phase II HBI-3000-402 trial.
The trial will analyse the safety, tolerability and anti-tumour activity of CFT8634 for treating SMARCB1-perturbed cancers.